Chosun University Hospital Receives 'Grade 1' in HIRA Respiratory Disease Appropriateness Evaluation

[Asia Economy Honam Reporting Headquarters Reporter Yoon Jamin] Chosun University Hospital (Director Jeong Jong-hoon) announced on the 15th that it was selected as ‘Grade 1’ in all categories in the recent adequacy evaluation related to respiratory diseases conducted by the Health Insurance Review and Assessment Service.

The HIRA evaluates the diagnosis and treatment processes of respiratory diseases and conducts medical adequacy assessments targeting diseases such as ‘asthma,’ ‘chronic obstructive pulmonary disease,’ and ‘lung cancer’ to improve the quality of medical care.

In this evaluation, Chosun University Hospital received a Grade 1 by comprehensively achieving high scores in areas such as ▲ pulmonary function test implementation rate ▲ continuous visit patient ratio ▲ inhaled bronchodilator prescription patient ratio, reflecting the continuity of examination and treatment. The ‘asthma’ adequacy evaluation also earned excellent grades in all indicators.

Additionally, in the ‘lung cancer’ adequacy evaluation, which ranks first in cancer mortality, the hospital demonstrated excellence in cancer treatment by scoring above average in overall areas including ▲ composition of specialized personnel ▲ lymph node dissection implementation rate ▲ radiation therapy ▲ chemotherapy administration.

Jeong Jong-hoon, director of Chosun University Hospital, said, “In addition to asthma, chronic obstructive pulmonary disease, and lung cancer, we have been recognized for the excellence of our medical services by achieving Grade 1 in various recent evaluations such as colorectal cancer and anesthesia adequacy assessments. We will continue to strive to improve the quality of medical care.”

This content was produced with the assistance of AI translation services.